Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
International Journal of Cancer
|
December 23, 2014
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer
Sonja Thaler, Gitta Thiede, Jan G Hengstler, et al.
Plos One
|
March 28, 2013
CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a
Santoshi Muppala, Giridhar Mudduluru, Jörg H Leupold, et al.
Cancers
|
March 29, 2023
Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases
Cristina L Cotarelo, Arno Schad, Marcus Schmidt, et al.
Experimental Dermatology
|
June 20, 2007
Switch in syndecan-1 and syndecan-4 expression controls maturation associated dendritic cell motility
Marco Averbeck, Carl Gebhardt, Ulf Anderegg, et al.
Clinical & Experimental Metastasis
|
July 26, 2018
Platelet deficiency in Tpo<sup>-/-</sup> mice can both promote and suppress the metastasis of experimental breast tumors in an organ-specific manner
Wilko Thiele, Melanie Rothley, Arno Dimmler, et al.
ACS Nano
|
February 20, 2016
Tin Tungstate Nanoparticles: A Photosensitizer for Photodynamic Tumor Therapy
Carmen Seidl, Jan Ungelenk, Eva Zittel, et al.
Cells
|
January 24, 2025
A Novel, Cell-Compatible Hyaluronidase Activity Assay Identifies Dextran Sulfates and Other Sulfated Polymeric Hydrocarbons as Potent Inhibitors for CEMIP
Anja Schmaus, Sofia Spataro, Paul Sallmann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 15, 2003
Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity
Anja-Katrin Bosserhoff, Raphael Stoll, Jonathan P Sleeman, et al.
Cancers
|
April 30, 2021
Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2- Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2- Breast Cancer
Sven Roßwag, Cristina L Cotarelo, Klaus Pantel, et al.
Seminars in Cancer Biology
|
March 1, 2012
Concepts of metastasis in flux: the stromal progression model
Jonathan P Sleeman, Gerhard Christofori, Riccardo Fodde, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
International Journal of Cancer
|
December 23, 2014
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer
Sonja Thaler, Gitta Thiede, Jan G Hengstler, et al.
Plos One
|
March 28, 2013
CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a
Santoshi Muppala, Giridhar Mudduluru, Jörg H Leupold, et al.
Cancers
|
March 29, 2023
Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases
Cristina L Cotarelo, Arno Schad, Marcus Schmidt, et al.
Experimental Dermatology
|
June 20, 2007
Switch in syndecan-1 and syndecan-4 expression controls maturation associated dendritic cell motility
Marco Averbeck, Carl Gebhardt, Ulf Anderegg, et al.
Clinical & Experimental Metastasis
|
July 26, 2018
Platelet deficiency in Tpo<sup>-/-</sup> mice can both promote and suppress the metastasis of experimental breast tumors in an organ-specific manner
Wilko Thiele, Melanie Rothley, Arno Dimmler, et al.
ACS Nano
|
February 20, 2016
Tin Tungstate Nanoparticles: A Photosensitizer for Photodynamic Tumor Therapy
Carmen Seidl, Jan Ungelenk, Eva Zittel, et al.
Cells
|
January 24, 2025
A Novel, Cell-Compatible Hyaluronidase Activity Assay Identifies Dextran Sulfates and Other Sulfated Polymeric Hydrocarbons as Potent Inhibitors for CEMIP
Anja Schmaus, Sofia Spataro, Paul Sallmann, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 15, 2003
Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity
Anja-Katrin Bosserhoff, Raphael Stoll, Jonathan P Sleeman, et al.
Cancers
|
April 30, 2021
Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2- Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2- Breast Cancer
Sven Roßwag, Cristina L Cotarelo, Klaus Pantel, et al.
Seminars in Cancer Biology
|
March 1, 2012
Concepts of metastasis in flux: the stromal progression model
Jonathan P Sleeman, Gerhard Christofori, Riccardo Fodde, et al.
Page
of 9